Swipe om te navigeren naar een ander artikel
The online version of this article (https://doi.org/10.1007/s10865-018-9954-3) contains supplementary material, which is available to authorized users.
Medication nonadherence is a significant clinical problem among individuals taking statins. Poor adherence is often attributable to several reasons, yet most adherence interventions target a single reason. Baseline data were examined from a randomized clinical trial of 236 patients with hyperlipidemia. A latent class analysis was then performed on patients reporting any nonadherence (n = 109). A 4-class solution provided the most optimal fit and differentiation of classes. Class 1 (N = 59, 54%) included patients who reported occasionally forgetting. Class 2 (N = 16, 14%) represented patients who were concerned about side effects. Class 3 (N = 17, 16%) represented patients who reported out-of-routine life events as contributing to nonadherence. Class 4 (N = 17, 16%) represented patients who endorsed a large number reasons indiscriminately. Class membership was almost uniformly unrelated to any patient demographic factors or treatment arm. Each cluster of reasons defining these patients may be best addressed through different intervention strategies.
Log in om toegang te krijgen
Met onderstaand(e) abonnement(en) heeft u direct toegang:
Supplementary material 1 (DOCX 18 kb)10865_2018_9954_MOESM1_ESM.docx
AlGhurair, S. A., Hughes, C. A., Simpson, S. H., & Guirguis, L. M. (2012). A systematic review of patient self-reported barriers of adherence to antihypertensive medications using the World Health Organization Multidimensional Adherence Model. The Journal of Clinical Hypertension,14, 877–886. CrossRefPubMed
Blalock, D. B., Zullig, L. L., Bosworth, H. B., Taylor, S., & Voils, C. I. (under review). Self-reported medication nonadherence predicts cholesterol levels, and demonstrates causal priority over time.
Bosworth, H. B., Blalock, D. V., Hoyle, R. H., Czajkowski, S., & Voils, C. I. (in press). The role of psychological science in efforts to improve cardiovascular medication adherence. American Psychologist.
Brown, I., Sheeran, P., & Reuber, M. (2009). Enhancing antiepileptic drug adherence: A randomized controlled trial. Epilepsy & Behavior,16, 634–639. CrossRef
Ho, P. M., Lambert-Kerzner, A., Carey, E. P., Fahdi, I. E., Bryson, C. L., Melnyk, S. D., et al. (2014). Multifaceted intervention to improve medication adherence and secondary prevention measures after acute coronary syndrome hospital discharge: A randomized clinical trial. JAMA Internal Medicine,174, 186–193. CrossRefPubMed
Linzer, D. A., & Lewis, J. B. (2011). poLCA: An R package for polytomous variable latent class analysis. Journal of Statistical Software,42, 1–29. CrossRef
Magidson, J., & Vermunt, J. (2002). Latent class models for clustering: A comparison with K-means. Canadian Journal of Marketing Research,20, 36–43.
Nieuwlaat, R., Wilczynski, N., Navarro, T., Hobson, N., Jeffery, R., Keepanasseril, A., Agoritsas, T., et al. (2014). Interventions for enhancing medication adherence. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.CD000011.pub4. PubMed
Sabaté, E. (Ed.). (2003). Adherence to long-term therapies: Evidence for action. Geneva: World Health Organization.
Stone, N. J., Robinson, J. G., Lichtenstein, A. H., Merz, C. N. B., Blum, C. B., Eckel, R. H., et al. (2014). 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Journal of the American College of Cardiology,63(25 Part B), 2889–2934. CrossRefPubMed
van Driel, M. L., Morledge, M. D., Ulep, R., Shaffer, J. P., Davies, P., & Deichmann, R. (2016). Interventions to improve adherence to lipid-lowering medication. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.CD004371.pub4.
Yang, C. C. (2006). Evaluating latent class analysis models in qualitative phenotype identification. Computational Statistics & Data Analysis,50, 1090–1104. CrossRef
Zhou, X. H., McClish, D. K., & Obuchowski, N. A. (2009). Statistical methods in diagnostic medicine (Vol. 569). Hoboken: Wiley.
- Co-occurring reasons for medication nonadherence within subgroups of patients with hyperlipidemia
Dan V. Blalock
Hayden B. Bosworth
Bryce B. Reeve
Corrine I. Voils
- Springer US
- Journal of Behavioral Medicine
Print ISSN: 0160-7715
Elektronisch ISSN: 1573-3521